CD8A and relapsing-remitting multiple sclerosis: We then performed Uniform Manifold Approximation and Projection (UMAP) analyses in CD3+CD8+ T lymphocytes from untreated RRMS patients and treated RRMS patients during FTY or NTZ therapies.